New research shows marijuana-based treatments could delay the progression of a fatal condition known as Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS). The study, published in the...
British drug maker GW Pharmaceuticals released the first results on the efficacy and safety of Epidiolex, a purified form of the marijuana compound cannabidiol (CBD), on Tuesday. The...
The state of Georgia has entered an agreement with GW Pharmaceuticals and Georgia Regents University to trial a marijuana-based epilepsy treatment according to a new article on...
A drug made from chemicals found in marijuana has entered human trials as a treatment for schizophrenia. GW Pharmaceuticals announced on Monday that it has started Phase 2 clinical...
Marijuana and epilepsy are in the news, Sanjay Gupta strikes again, and state houses across the country are grappling with medical marijuana and CBD bills. Let’s get...
France’s ministry of health announced Thursday that it has approved Sativex, a cannabis-based mouth spray produced by GW pharmaceutricals. Sativex will be available in France in 2015...
As knowledge of cannabis as a viable treatment for cancer and epilepsy for children becomes more accepted – even the FDA has now approved CBD to treat kids...
Irish Minister of State Alex White said he plans to “amend the regulations to allow a newly authorized medicinal product containing cannabis extract to be prescribed (Sativex), supplied...
While it’s apparently taken centuries for scientists to take serious notice of the medical effects of the cannabis plant, virtually all the attention has been on THC,...
GW Pharmaceuticals has launched their Sativex cannabis extract spray in Italy for use by Multiple Sclerosis (MS) patients. Beware of GW’s creeping monopoly on medical marijauna in...
GW Pharmaceuticals plc (GWP), the maker of Sativex and undeniably the original marijuana stock, files for U.S. IPO after recent interest in lesser-known but more hyped U.S. medical...
Epilepsy is a serious medical condition noted chiefly for recurrent brain seizures, affecting many millions of people across the world. Typical pharmaceutical treatments have side effects, often...
Ben Whalley at the University of Reading, UK, and colleagues worked with GW Pharmaceuticals in Wiltshire, UK, to investigate the anti-convulsant properties of cannabidivarin (CBDV), a little-studied chemical found in...
The Irish Department of Health says it hopes to bring forward legislative proposals this year, or in early 2013, enabling cannabis-based medicines to be prescribed in Ireland.
